• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
    • Fat Tail Daily
    • James Cooper’s Mining Memo
    • The Daily Reckoning Australia
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services

Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations

ASX MSB - Mesoblast Share Price

Mesoblast Share Price Up on Encouraging COVID-19 Trails (ASX:MSB)

At time of writing, the Mesoblast Ltd [ASX:MSB] share price is up 4.47%, trading at $3.27. The MSB share price moved higher after announcing positive outcomes in relation to Remestemcel-L phase three trials…

By Carl Wittkopp, Wednesday, 11 November 2020

IHL Share Price - Incannex Shares

Incannex Share Price Up 8% as It Declares Impressive Clinical Trial Result

It’s been a big night for pot stocks in the US. With a nail-biting election that could dramatically impact the future of cannabis legality. But, back in Australia, local pot stock Incannex Healthcare Ltd (ASX:IHL) has had a big day too. The IHL share price is up 7.69% at time of writing…

By Ryan Clarkson-Ledward, Thursday, 05 November 2020

ASX AT1 Share Price - Atomo Diagnostics ASX

Atomo Diagnostics Share Price Up on Increased Revenue (ASX:AT1)

The medical device company experienced a huge growth in revenue in FY20. Atomo Diagnostics Ltd’s [ASX:AT1] boost is primarily driven by the acceleration of HIV rollout via Mylan. This saw the AT1 share price move up 3.03% to 34 cents at the time of writing…

By Carl Wittkopp, Wednesday, 04 November 2020

ASX RSH Share Price - Respiri Shares ASX

Respiri Reports Reductions in Overheads as Share Price Climbs Higher

It’s been a bumpy road of development for Respiri Ltd [ASX:RSH]. Today though, with an early gain of 12.9%, The RSH share price seems to be heading back in the right direction. So, what was behind the turnaround?

By Ryan Clarkson-Ledward, Wednesday, 04 November 2020

ASX RCE Share Price - Recce Pharmaceuticals ASX

Recce Pharmaceuticals Shares Lift as It Pushes Closer to New Trials

2020 has been a busy year for Recce Pharmaceuticals Ltd [ASX:RCE]. The biotech small-cap has been tirelessly putting their synthetic anti-infectives to the test. However, as with any new medicine or treatment, they must first pass intensive trials…

By Ryan Clarkson-Ledward, Friday, 16 October 2020

ASX DXB Share Price - Dimerix Share Price

Dimerix Share Price Rises 9% on Positive Results (ASX:DXB)

Shares of Melbourne-based biotechnology company Dimerix Ltd [ASX:DXB] have gained 9% today, to trade at 32 cents at the time of writing. The DXB share price rose on the back of encouraging results that will support…

By Carl Wittkopp, Wednesday, 07 October 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Interim pages omitted …
  • Page 28
  • Go to Next Page »

Primary Sidebar

Technology Categories

  • Technology
  • Artificial Intelligence
  • Bitcoin
  • Cryptocurrency
  • Energy
  • Financial Technology
  • Bio Technology

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988